Angiogenic growth factor

A study has demonstrated the first successful utilization of a photosynthetic system as a means of correcting tissue ischemia. The...


Lenvatinib mesylate ( Lenvima ) is an orally administered multiple receptor tyrosine kinase ( RTK ) inhibitor with a novel...


The U.S. Food and Drug Administration ( FDA ) has approved an additional indication for Lenvima ( Lenvatinib mesylate )...


The European Commission ( EC ) has issued a marketing authorisation for Kisplyx ( Lenvatinib ) in combination with Everolimus...


Study 205 is a multicenter, randomized, open-label study of Lenvatinib ( 18 mg ) in combination with the anticancer agent...


Lenvatinib ( Lenvima ) is an orally administered multiple receptor tyrosine kinase ( RTK ) inhibitor with a novel binding...


Endothelial dysfunction, characterized by diminished endothelial progenitor cell ( EPC ) function and flow-mediated vasodilation ( FMD ), is a...


The FDA ( Food and Drug Administration ) has approved Ramucirumab ( Cyramza ) in combination with Paclitaxel as a...


Glioblastoma ( GBM ) is the most common primary malignant adult brain tumor and, despite treatment advances in recent years,...


Glioblastoma is the most common primary malignant brain tumor in adults and, despite treatment advances in recent years, the average...


VEGF-D is a lymphangiogenic growth factor that has a key role in tumour metastasis. Serum VEGF-D concentrations are increased in...


Genetic variations ensure that no two people are exactly alike, nor are their cancers. Researchers now have the tools and...


The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily...


Researchers at National Jewish Medical and Research Center reported in Cancer Research that a pair of promising proteins, known as...


Researchers at Beth Israel Deaconess Medical Center ( BIDMC ), in collaboration with a research team from The Hospital for...


Vascular anomalies, caused by abnormal development of arteries, capillaries, veins or lymph vessels, can sometimes begin to progress, requiring aggressive...


Using a novel model for scleroderma, researchers from Duke University Medical Center have discovered two important insights into this devastating...